These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10618292)

  • 1. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans.
    Hua J; Meyer JD; Lodge JK
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):125-8. PubMed ID: 10618292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Going green in Cryptococcus neoformans: the recycling of a selectable drug marker.
    Patel RD; Lodge JK; Baker LG
    Fungal Genet Biol; 2010 Mar; 47(3):191-8. PubMed ID: 19944774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new dominant selectable marker for use in Cryptococcus neoformans.
    McDade HC; Cox GM
    Med Mycol; 2001 Feb; 39(1):151-4. PubMed ID: 11270405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic transformation of Trametes versicolor to phleomycin resistance with the dominant selectable marker shble.
    Bartholomew K; Dos Santos G; Dumonceaux T; Charles T; Archibald F
    Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):201-4. PubMed ID: 11499931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Cryptococcus neoformans isolated from urban environmental sources in Goiânia, Goiás State, Brazil.
    Kobayashi CC; Souza LK; Fernandes Ode F; Brito SC; Silva AC; Sousa ED; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2005; 47(4):203-7. PubMed ID: 16138201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
    Dromer F; Gueho E; Ronin O; Dupont B
    J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection caused by Cryptococcus neoformans var. gattii serotype B in an AIDS patient in India.
    Abraham M; Mathews V; Ganesh A; John TJ; Mathews MS
    J Med Vet Mycol; 1997; 35(4):283-4. PubMed ID: 9292426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G418, phleomycin and hygromycin selection of recombinant Trypanosoma brucei parasites refractory to long-term in vitro culture.
    Uzureau P; Felu C; De Muylder G; Pays E; Vanhamme L
    Mol Biochem Parasitol; 2007 Jul; 154(1):90-4. PubMed ID: 17449118
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.
    Ikeda R; Shinoda T; Fukazawa Y; Kaufman L
    J Clin Microbiol; 1982 Jul; 16(1):22-9. PubMed ID: 6179964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcal meningitis in an alpaca.
    Goodchild LM; Dart AJ; Collins MB; Dart CM; Hodgson JL; Hodgson DR
    Aust Vet J; 1996 Dec; 74(6):428-30. PubMed ID: 9006855
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain.
    Baró T; Torres-Rodríguez JM; Morera Y; Alía C; López O; Méndez R
    J Clin Microbiol; 1999 Apr; 37(4):1170-2. PubMed ID: 10074545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.
    Gerstein AC; Jackson KM; McDonald TR; Wang Y; Lueck BD; Bohjanen S; Smith KD; Akampurira A; Meya DB; Xue C; Boulware DR; Nielsen K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of Cryptococcus neoformans meningitis in a patient with abnormal levels of isolated immunological markers.
    Simsek B; Guven E; Gumral R; Mert G; Saracli MA; Besirbellioglu B; Yildiran ST
    J Mycol Med; 2016 Sep; 26(3):283-5. PubMed ID: 27402508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotyping of Cryptococcus neoformans by dot enzyme assay.
    Belay T; Cherniak R; O'Neill EB; Kozel TR
    J Clin Microbiol; 1996 Feb; 34(2):466-70. PubMed ID: 8789042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ble gene of Streptoalloteichus hindustanus as a new selectable marker for Dictyostelium discoideum confers resistance to phleomycin.
    Leiting B; Noegel AA
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1403-7. PubMed ID: 1953786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.
    Peetermans W; Bobbaers H; Verhaegen J; Vandepitte J
    Acta Clin Belg; 1993; 48(6):405-9. PubMed ID: 8128821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human defenses against Cryptococcus neoformans: an update.
    Brummer E
    Mycopathologia; 1998-1999; 143(3):121-5. PubMed ID: 10353206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant selection system for use in Cryptococcus neoformans.
    Cox GM; Toffaletti DL; Perfect JR
    J Med Vet Mycol; 1996; 34(6):385-91. PubMed ID: 8971627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.